Dachaigh › Macroglobulinemia Waldenstrom
Sgrùdaidhean clionaigeach Macroglobulinemia Waldenstrom a’ fastadh anns na SA
Tha 30 sgrùdaidhean airson Macroglobulinemia Waldenstrom a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Durham, NC10 sgrùdaidhean
- Boston, MA9 sgrùdaidhean
- Denver, CO7 sgrùdaidhean
- Rochester, MN6 sgrùdaidhean
- New York City, NY6 sgrùdaidhean
- Houston, TX6 sgrùdaidhean
- Dallas, TX6 sgrùdaidhean
- Edison, NJ6 sgrùdaidhean
- Seattle, WA5 sgrùdaidhean
- Milwaukee, WI5 sgrùdaidhean
- Washington, DC4 sgrùdaidhean
- Baldwin Park, CA4 sgrùdaidhean
- Columbus, OH4 sgrùdaidhean
- Chicago, IL4 sgrùdaidhean
- Queens, NY4 sgrùdaidhean
- Richmond, VA3 sgrùdaidhean
- Nashville, TN3 sgrùdaidhean
- Miami, FL3 sgrùdaidhean
- Jacksonville, FL3 sgrùdaidhean
- Salt Lake City, UT3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Philadelphia, PA3 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
- Portland, OR3 sgrùdaidhean
Le stàit
- Arizona4 sgrùdaidhean
- California11 sgrùdadh
- Colorado8 sgrùdaidhean
- Florida7 sgrùdaidhean
- Georgia3 sgrùdaidhean
- Illinois5 sgrùdaidhean
- Iowa3 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts11 sgrùdadh
- Michigan5 sgrùdaidhean
- Minnesota6 sgrùdaidhean
- New Jersey7 sgrùdaidhean
- New York8 sgrùdaidhean
- North Carolina12 sgrùdaidhean
- Ohio8 sgrùdaidhean
- Oregon3 sgrùdaidhean
- Pennsylvania3 sgrùdaidhean
- Tennessee3 sgrùdaidhean
- Texas11 sgrùdadh
- Utah3 sgrùdaidhean
- Virginia3 sgrùdaidhean
- Washington7 sgrùdaidhean
- Wisconsin6 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05006716ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07420959Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04728893A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07231952Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00923507Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04840602A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06561347A Study of ARC-02 in B-cell NHL
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07691606AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06340737Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07426484Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05640102A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06708897A Study of APG-3288 in Relapsed/Refractory Blood Cancers
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07424833A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05131022Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06860880Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2026 · NCT02269592SynKIR-310 for Relapsed/Refractory B-NHL
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT06544265A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Màrt 2026 · NCT04830137Epcoritamab in Previously Treated WM
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT06510491Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT06151730Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT04775745Study of SGR-1505 in Mature B-Cell Neoplasms
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT05544019AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Dùbh 2025 · NCT05602363Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.